Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay
|2||Active, not recruiting||
Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy
Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas
† Study has passed its completion date and status has not been verified in more than two years.